Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-03

Clinical Trial Update: Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities [NA]

View source ↗

Summary

A recruiting clinical trial aims to prevent oxaliplatin-induced peripheral neuropathy in colorectal cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vejle Hospital | Conditions: Peripheral Neuropathy, Colorectal Cancer | NA | Status: RECRUITING